α2-Heremans-schmid glycoprotein (fetuin A) downregulation and its utility in inflammatory bowel disease

Abstract

AHSG can be used to distinguish between IBD and IBS patients or HC while at the same time "predicting" complicated disease behavior, need for therapy escalation and surgery. Moreover, AHSG may offer new insights into the pathogenesis of IBD, since it is involved in key processes.